A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM
Public ClinicalTrials.gov record NCT03090464. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Real-world, Point-of-care, Randomized, Parallel Group, Open, 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Type 2 diabetes mellitus is a complex, chronic disease that requires a comprehensive treatment plan aimed at meeting multitude therapeutic targets associated with micro- and macro-vascular risk reduction. There is evidence that patient support in various forms can have a significant positive impact on adherence to treatment and the meeting of targets in patients with type 2 diabetes mellitus. The purpose of this study is to evaluate if the use of a digital disease management tool (Smart phone- web portal-based tool), in addition to Standard of Care for T2DM, will improve glycemic control. Other variables important in T2DM (such as weight, blood pressure, and lipid levels), will also be evaluated along with patient-reported outcomes, such as satisfaction with treatment and adherence to their antihyperglycemic treatment. Study duration is 6 months
Study identification
- NCT ID
- NCT03090464
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 328 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 8, 2017 (Actual)
- Primary completion
- May 21, 2018 (Actual)
- Completion
- May 21, 2018 (Actual)
- Last update posted
- May 9, 2019
2017 – 2018
United States locations
- U.S. sites
- 46
- U.S. states
- 21
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35209 | — |
| Research Site | Birmingham | Alabama | 35216 | — |
| Research Site | Peoria | Arizona | 85381 | — |
| Research Site | Surprise | Arizona | 85374 | — |
| Research Site | Lincoln | California | 95648 | — |
| Resezrch Site | Montclair | California | 91763 | — |
| Research Site | North Hollywood | California | 91606 | — |
| Research Site | Spring Valley | California | 91978 | — |
| Research Site | Van Nuys | California | 91405 | — |
| Research Site | Colorado Springs | Colorado | 80906 | — |
| Research Site | Cooper City | Florida | 33024 | — |
| Research Site | DeLand | Florida | 32720 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Reserarch Site | Jacksonville | Florida | 32277 | — |
| Research Site | Lake City | Florida | 32055 | — |
| Research Site | Ormond Beach | Florida | 32174 | — |
| Research Site | Pembroke Pines | Florida | 33026 | — |
| Research Site | Port Orange | Florida | 32127 | — |
| Research Site | Tampa | Florida | 33634 | — |
| Research Site | Evanston | Illinois | 60201 | — |
| Research Site | Lexington | Kentucky | 40503 | — |
| Research Site | Oxon Hill | Maryland | 20745 | — |
| Research Site | Omaha | Nebraska | 68134 | — |
| Research Site | Las Vegas | Nevada | 89128 | — |
| Research Site | Albuquerque | New Mexico | 87102 | — |
| Research Site | Brooklyn | New York | 11235 | — |
| Research Site | New Windsor | New York | 12553 | — |
| Research Site | Westfield | New York | 14787 | — |
| Research Site | Greensboro | North Carolina | 27410 | — |
| Research Site | Franklin | Ohio | 45005 | — |
| Research Site | Downingtown | Pennsylvania | 19335 | — |
| Research Site | Charleston | South Carolina | 29407 | — |
| Research Site | Greer | South Carolina | 29651 | — |
| Research Site | Myrtle Beach | South Carolina | 29588 | — |
| Research Site | Spartanburg | South Carolina | 29301 | — |
| Research Site | Tullahoma | Tennessee | 37388 | — |
| Research Site | Houston | Texas | 77040 | — |
| Research Site | Houston | Texas | 77058 | — |
| Research Site | Lampasas | Texas | 76550 | — |
| Research Site | Plano | Texas | 75024 | — |
| Research Site | Salt Lake City | Utah | 84107 | — |
| Research Site | Burke | Virginia | 22015 | — |
| Research Site | Manassas | Virginia | 20110 | — |
| Research Site | Richmond | Virginia | 23235 | — |
| Research Site | Federal Way | Washington | 98003 | — |
| Research Site | Olympia | Washington | 98502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03090464, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2019 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03090464 live on ClinicalTrials.gov.